Key Takeaways Eni has signed a 50:50 joint venture agreement with PETRONAS to merge upstream assets in Asia. The new entity will hold 3B boe in reserves and aims for 500K boepd output, mainly from natural gas. The venture targets over 50 TCF of low-risk gas and 10B boe in exploration across Indonesia and Malaysia.Italian energy major Eni S.p.A. (E) has signed a major Framework Agreement with Malaysian state energy giant PETRONAS to merge their upstream oil and gas assets in Indonesia and Malaysia, paving ...

More than 5 years of experience in equity analysis in LatAm. We provide our clients with in-depth research and insights to help them make informed investment decisions.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relati ...

US$3.0 Million Investment for Exploration and Restart Plan, Shares for Debt Transactions and Notice of Annual General Meeting and Special MeetingTORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQB: GALKF) (“Galantas” or the “Company”) is pleased to announce that it has entered into a Binding Term Sheet with Ocean Partners UK Limited (“Ocean Partners”) on June 6, 2025 to joint venture the high-grade Omagh Gold Project in County Tyrone, Northern Ireland (the “Omagh Pr ...

住宅开发用地的价格在过去五年中暴涨了 75%，让澳洲普通人买房的梦想更加遥不可及。 Ray White 基于 Real Capital Analytics 数据的分析显示，住宅开发地块的中位价格已从 2020 年的 480 万 澳元，涨至今年的 850 万澳元。 与此同时，建筑成本依然远高于 COVID-19疫情前水平，进一步加剧了住房可负担性危机。 Ray White 首席经济学家 Nerida Conisbee 表示，要等到建筑成本降到能真正造出普通人买得起的新房， 还需要"很长时间"。 "地价没有跌，开发商也想建房，但根本建不出负担得起的房子，"Conisbee 说，"我们并没 有看到像以往那样的市场崩盘，现在更像是停滞的拉锯状态。" 开发商不愿卖地，银行也"不逼债" 以往每逢经济下行周期，利率上升往往会迫使部分地块业主"割肉"，以低价抛售土地。但这次不同，许 多开发商在疫情期间的低利率时代已经建立了足够的财务缓冲，能抗得住。 他们还通过 合资开发（Joint Venture）分摊压力。银行方面也改变策略，不像以往那样快速清算开发 商资产，更倾向于提供财务宽限。 目标是五年内建 120 万套房，现实却是 ...

Company Overview - Almadex Minerals Ltd. has acquired the area covering most of the historic Petaca District in northern New Mexico through staking, as part of its regional exploration program focused on copper-gold potential [1] - The company holds a large mineral portfolio consisting of projects and NSR royalties in Canada, the U.S., and Mexico, and has significant experience in porphyry lithocap exploration [6] Exploration Focus - The Petaca District has a history of mica production and contains rare earth element (REE) bearing minerals, which were occasionally recovered as by-products of mica mining [2] - Almadex's exploration program prioritizes porphyry lithocaps and epithermal precious metal systems, although REE projects are not the company's core focus [4][5] Technical Insights - The pegmatites in the Petaca District exhibit various forms and have been noted for their elevated REE concentrations, primarily reflecting the mineral samarskite [2] - A microprobe study confirmed the presence of several minerals, including Samarskite-(Y) and polycrase-(Y), indicating a high level of niobium (Nb) and yttrium (Y) in accessory minerals [3] Future Plans - The company intends to seek a joint venture partner with expertise in REE mineral systems to explore the Petaca District [4][5] - Almadex plans to advance and test its lithocap targets in 2025, leveraging its in-house exploration capacity and drilling units [6]

The partnership combines Lennox's strength in residential distribution and customer relationships with Ariston Group's advanced water heating technology and manufacturing footprint, to launch water heaters that will carry the Lennox brands. DALLAS, May 27, 2025 /PRNewswire/ -- Lennox (NYSE: LII), a leader of innovative climate solutions in the HVACR industry, and Ariston Group (Bloomberg: ARIS IM), a global leader in sustainable climate and water comfort, have entered into a joint venture that will bring a ...

STERIS' (STE) new acquisitions and partnerships strengthen its product offerings. The stock carries a Zacks Rank #2 (Buy) currently.Factors Driving STERIS' GrowthSTERIS’ Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Further, its services to maintain that equipment, repair reusable procedural instruments and outsource instrument reprocessing services are gaining traction. For the fourth quart ...

Summary of Darling Ingredients Inc. Conference Call Company and Industry - **Company**: Darling Ingredients Inc. - **Industry**: Collagen and Gelatin Production, Health and Wellness Sector Key Points and Arguments 1. **Joint Venture Announcement**: Darling Ingredients announced a nonbinding term sheet with the Centrelo Group to form a new joint venture called NexTita, with Darling holding an 85% stake and Centrelo holding 15% [4][5][21] 2. **Revenue Expectations**: The new company is projected to generate annual revenue of approximately $1.5 billion, with significant growth potential and attractive margins [5][21] 3. **Production Capacity**: NexTita will have gelatin and collagen production capacity of around 200,000 metric tons annually across 23 facilities in nine countries [5][6] 4. **Market Position**: The joint venture aims to create a leading company in the collagen-based health, wellness, and nutrition market, which is still in its early stages of development [6][7] 5. **Focus on Innovation**: Darling Ingredients has nearly a dozen product concepts in development, emphasizing science and innovation in the health and wellness sector [7][8] 6. **Financial Strategy**: The merger is designed to optimize shareholder value without leveraging debt, potentially leading to deleveraging [9][21] 7. **Market Dynamics**: The food segment's contribution to margins and growth potential has not been fully recognized, and the merger aims to highlight this value [8][9] 8. **Supply Chain Management**: The combined entity will enhance supply chain management capabilities, which is crucial for maintaining consistent margins [13][14] 9. **Future Growth**: The joint venture is expected to diversify the portfolio and enhance growth in hydrolyzed collagen, which has seen significant demand [39][41] 10. **Regulatory Considerations**: The joint venture will undergo regulatory approvals, and the companies believe they will not dominate the market share significantly [58][59] Additional Important Content 1. **Market Size**: The global collagen market is estimated to be between $60 billion, with the joint venture representing a minor player in this space [59][60] 2. **Capital Allocation**: There are no expected significant changes in capital allocation for the joint venture, as both companies have maintained their assets well [41][61] 3. **Potential IPO**: There is a possibility of taking the joint venture public in the future, depending on market conditions and growth [24][62] 4. **Raw Material Sourcing**: The joint venture will benefit from diversified sourcing of raw materials, reducing risks associated with supply chain bottlenecks [68][71] 5. **Strategic Relationships**: The merger will leverage existing relationships and technologies from both companies to enhance market reach and product development [66][67] This summary encapsulates the key discussions and insights from the Darling Ingredients Inc. conference call, focusing on the formation of the joint venture and its implications for the company and the industry.

ICU Medical (ICUI) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants John Mills - Managing PartnerVivek Jain - Chairman & Chief Executive OfficerBrian Bonnell - Chief Financial OfficerJayson Bedford - Managing Director - Medical TechnologyJoseph Conway - Equity Research Associate Conference Call Participants Brett Fishbin - Vice President & Equity Research AnalystLarry Solow - Partner & Managing director - Equity AnalystMichael Toomey - US Medtech Analyst Operator Good day, and welcome to ...

VANCOUVER, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) has today filed its interim financial results for the first quarter ended March 31, 2025. All numbers are in U.S. dollars unless otherwise noted. Q1 2025 HIGHLIGHTS Arbitration and Entrée/Oyu Tolgoi JVA On December 19, 2024, a partial final award (the “Award”) was made by the three-member international arbitration Tribunal appointed in connection with the Company’s binding a ...